Overview

Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of Hepalatide(L47) and characterize the clinical pharmacokinetics in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai HEP Pharmaceatical Co., Ltd.